TY - JOUR
T1 - Spherical Cocrystallization - An Enabling Technology for the Development of High Dose Direct Compression Tablets of Poorly Soluble Drugs
AU - Chen, Hongbo
AU - Guo, Yiwang
AU - Wang, Chenguang
AU - Dun, Jiangnan
AU - Sun, Changquan Calvin
PY - 2019/4/3
Y1 - 2019/4/3
N2 - Spherical cocrystallization (SCC), an integrated crystal and particle engineering approach, was successfully applied to generate spherical cocrystal agglomerates (SCA) between a poorly soluble drug, griseofulvin (GSF) and acesulfame (Acs). The SCC process consists of two steps: (1) GSF-Acs cocrystal formation by reaction crystallization in a slurry; (2) agglomeration by adding a bridging liquid. The obtained SCA exhibited superior mechanical and powder properties over GSF. Inclusion of a small amount (<1%) HPC in the agglomerates improved both the tabletability and dissolution performance. Using the SCA, a high GSF loading (55.7%) direct compression tablet formulation was successfully developed, which exhibited much improved manufacturability and drug release property over GSF based tablet formulation.
AB - Spherical cocrystallization (SCC), an integrated crystal and particle engineering approach, was successfully applied to generate spherical cocrystal agglomerates (SCA) between a poorly soluble drug, griseofulvin (GSF) and acesulfame (Acs). The SCC process consists of two steps: (1) GSF-Acs cocrystal formation by reaction crystallization in a slurry; (2) agglomeration by adding a bridging liquid. The obtained SCA exhibited superior mechanical and powder properties over GSF. Inclusion of a small amount (<1%) HPC in the agglomerates improved both the tabletability and dissolution performance. Using the SCA, a high GSF loading (55.7%) direct compression tablet formulation was successfully developed, which exhibited much improved manufacturability and drug release property over GSF based tablet formulation.
UR - http://www.scopus.com/inward/record.url?scp=85063147181&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063147181&partnerID=8YFLogxK
U2 - 10.1021/acs.cgd.9b00219
DO - 10.1021/acs.cgd.9b00219
M3 - Article
AN - SCOPUS:85063147181
SN - 1528-7483
VL - 19
SP - 2503
EP - 2510
JO - Crystal Growth and Design
JF - Crystal Growth and Design
IS - 4
ER -